Anzeige
Mehr »
Samstag, 11.10.2025 - Börsentäglich über 12.000 News
3 kritische Rohstoffe. 1 riesiges Becken. $2,26 Mrd. US-Finanzierung: Diese Aktie könnte die Nächste sein!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A2DU8Q | ISIN: CA74141E1043 | Ticker-Symbol: 18H
Stuttgart
10.10.25 | 07:44
0,014 Euro
-15,15 % -0,003
Branche
Gesundheitswesen
Aktienmarkt
Sonstige
1-Jahres-Chart
PREVECEUTICAL MEDICAL INC Chart 1 Jahr
5-Tage-Chart
PREVECEUTICAL MEDICAL INC 5-Tage-Chart
RealtimeGeldBriefZeit
0,0110,02810.10.

Aktuelle News zur PREVECEUTICAL MEDICAL Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
00:06Preveceutical Medical Inc: Preveceutical hikes placement, releases AGSM results2
FrPreveCeutical Medical Inc.: PreveCeutical Announces Results from Annual General and Special Meeting and Increase to Size of Non-Brokered Private Placement225Vancouver, British Columbia--(Newsfile Corp. - October 10, 2025) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) (the "Company" or "PreveCeutical"), is pleased to announce that all...
► Artikel lesen
20.09.Preveceutical Medical Inc: Preveceutical mails documents for Oct. 10 AGM4
20.09.PreveCeutical Medical Inc.: PreveCeutical Announces Mailing and Filing of Annual General and Special Meeting Materials in Connection with a Proposed Arrangement with BioGene Therapeutics829Vancouver, British Columbia--(Newsfile Corp. - September 19, 2025) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) (the "Company" or "PreveCeutical"), announces that further to its...
► Artikel lesen
06.09.Preveceutical Medical Inc: Preveceutical closes $646,500 tranche one of placement4
05.09.PreveCeutical Medical Inc.: PreveCeutical Closes Initial Tranche of Non-Brokered Private Placement774Vancouver, British Columbia--(Newsfile Corp. - September 5, 2025) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) (the "Company" or "PreveCeutical"), is pleased to announce that...
► Artikel lesen
04.09.PreveCeutical Medical Inc.: PreveCeutical Announces Arrangement Agreement with BioGene Therapeutics404Vancouver, British Columbia--(Newsfile Corp. - September 4, 2025) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE:18H) (the "Company" or "PreveCeutical") announces that it has entered...
► Artikel lesen
PREVECEUTICAL MEDICAL Aktie jetzt für 0€ handeln
29.08.Preveceutical Medical Inc: Preveceutical reschedules AGM to Oct. 102
29.08.PreveCeutical Medical Inc.: PreveCeutical Announces Rescheduled Date for Annual General and Special Meeting and Director Resignation536Vancouver, British Columbia--(Newsfile Corp. - August 28, 2025) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE:18H) (the "Company" or "PreveCeutical") announces that, further to its News...
► Artikel lesen
20.08.Preveceutical Medical Inc: Preveceutical's BioGene appoints chief tech officer1
20.08.PreveCeutical Medical Inc.: BioGene Therapeutics Inc. Appoints Dr. Francis Tavares, PhD., as Chief Technology Officer360Vancouver, British Columbia--(Newsfile Corp. - August 20, 2025) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE:18H) ("PreveCeutical" or the "Company"), a health sciences company that...
► Artikel lesen
19.08.Preveceutical Medical Inc: Preveceutical's BioGene appoints research director1
19.08.PreveCeutical Medical Inc.: BioGene Therapeutics Inc. Appoints Dr. Kamal Albarazanji as Senior Director of Metabolic Research205Vancouver, British Columbia--(Newsfile Corp. - August 19, 2025) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE:18H) ("PreveCeutical" or the "Company"), a health sciences company that...
► Artikel lesen
05.08.Preveceutical Medical Inc: Preveceutical further reschedules AGSM to Sept. 293
09.07.Preveceutical Medical Inc: Preveceutical Medical reschedules AGSM to Sept. 55
09.07.PreveCeutical Medical Inc.: PreveCeutical Announces Rescheduled Date for Annual General and Special Meeting246Vancouver, British Columbia--(Newsfile Corp. - July 9, 2025) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) (the "Company" or "PreveCeutical"), announces that, further to its News...
► Artikel lesen
01.07.Preveceutical Medical Inc: Preveceutical appoints Tavares chief technology officer2
30.06.PreveCeutical Medical Inc.: PreveCeutical Welcomes Dr. Francis Tavares, PhD. As Chief Technology Officer383Vancouver, British Columbia--(Newsfile Corp. - June 30, 2025) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) ("PreveCeutical" or the "Company"), a health sciences company that develops...
► Artikel lesen
25.06.Preveceutical Medical Inc: Preveceutical to hold AGM Aug. 152
25.06.PreveCeutical Medical Inc.: PreveCeutical Announces Date for Annual General and Special Meeting226Vancouver, British Columbia--(Newsfile Corp. - June 25, 2025) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) (the "Company" or "PreveCeutical"), is pleased to announce that it has...
► Artikel lesen
Weiter >>
52 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1